NasdaqGM - Nasdaq Real Time Price • USD
Centogene N.V. (CNTG)
As of April 25 at 4:00 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2023) | Next Qtr. (Jun 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | -- |
| Avg. Estimate | 0 | 0 | -1.71 | 0 |
| Low Estimate | 0 | 0 | -1.71 | 0 |
| High Estimate | 0 | 0 | -1.71 | 0 |
| Year Ago EPS | -0.49 | -0.47 | -1.32 | -1.71 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2023) | Next Qtr. (Jun 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | 26.32M | 52.02M | 63.01M |
| Low Estimate | 13.5M | 14.03M | 52.02M | 63.01M |
| High Estimate | 13.5M | 14.03M | 52.02M | 63.01M |
| Year Ago Sales | 10.52M | 11.96M | 52.81M | 52.02M |
| Sales Growth (year/est) | -- | 120.00% | -1.50% | 21.10% |
Earnings History
| CURRENCY IN USD | 3/31/2022 | 6/30/2022 | 9/30/2022 | 12/31/2022 |
|---|---|---|---|---|
| EPS Est. | -0.54 | -0.42 | -0.44 | -0.41 |
| EPS Actual | -0.49 | -0.47 | -0.52 | -0.1 |
| Difference | 0.05 | -0.05 | -0.08 | 0.31 |
| Surprise % | 9.30% | -11.90% | -18.20% | 75.60% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2023) | Next Qtr. (Jun 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -1.71 | 0 |
| 7 Days Ago | -0.4 | -0.39 | -1.71 | -1.06 |
| 30 Days Ago | -0.4 | -0.39 | -1.73 | -1.06 |
| 60 Days Ago | -0.4 | -0.39 | -1.73 | -1.05 |
| 90 Days Ago | -0.4 | -0.39 | -1.74 | -1.06 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2023) | Next Qtr. (Jun 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | CNTG | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 1.50% |
| Next Qtr. | -- | -- | -- | 12.10% |
| Current Year | -29.50% | -- | -- | 4.40% |
| Next Year | -- | -- | -- | 13.20% |
| Next 5 Years (per annum) | -- | -- | -- | 10.97% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/28/2023 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/18/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 4/27/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 4/13/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 4/12/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 2/22/2023 |
Related Tickers
ACRS Aclaris Therapeutics, Inc.
1.1900
0.00%
XGN Exagen Inc.
1.4100
+0.71%
MYNZ Mainz Biomed N.V.
0.8110
-5.35%
BNR Burning Rock Biotech Limited
0.7864
-7.48%
E08A.F Exagen Inc.
1.3000
+3.17%
IJF.SG Icon PLC
278.80
+0.87%
ANPCF ANGLE plc
0.1964
0.00%
ANPCY ANGLE plc
1.8900
0.00%
BIAFW bioAffinity Technologies, Inc.
0.4500
+12.50%
MVF.AX Monash IVF Group Limited
1.4450
-4.30%